2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
1990 <1990

 

Reference List:

    2000

     

  1. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy.
    Aronoff-Spencer E, Burns CS, Avdievich NI, Gerfen GJ, Peisach J, Antholine WE, Ball HL, Cohen FE, Prusiner SB, Millhauser GL.
    Biochemistry 2000, 39: 13760-71   Medline

     

  2. Peptides as Models for the Conformational Change in the Prion Protein.
    Baldwin MA, Cohen FE, Prusiner SB.
    In Prion Diseases: Current State and Perspectives in Prion Research ed H Kretzschmar and D Reisner Chapman and Hall Weinheim, Germany 2000 pp..

     

  3. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV, Aagaard C, Mehlhorn I, Wille H, Groth D, Baldwin MA, Prusiner SB, Cohen FE.
    Biochemistry 2000, 39: 2792-804   Medline

     

  4. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha.
    Bogan AA, Dallas-Yang Q, Ruse MD Jr, Maeda Y, Jiang G, Nepomuceno L, Scanlan TS, Cohen FE, Sladek FM.
    J Mol Biol 2000, 302: 831-51   Medline

     

  5. Prions, peptides and protein misfolding.
    Cohen FE.
    Mol Med Today 2000, 6: 292-3   Medline

     

  6. Aryl ureas represent a new class of anti-trypanosomal agents.
    Du X, Hansell E, Engel JC, Caffrey CR, Cohen FE, McKerrow JH.
    Chem Biol 2000, 7: 733-42   Medline

     

  7. Co-evolution of proteins with their interaction partners.
    Goh CS, Bogan AA, Joachimiak M, Walther D, Cohen FE.
    J Mol Biol 2000, 299: 283-93   Medline

     

  8. A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice.
    Kaneko K, Ball HL, Wille H, Zhang H, Groth D, Torchia M, Tremblay P, Safar J, Prusiner SB, DeArmond SJ, Baldwin MA, Cohen FE.
    J Mol Biol 2000, 295: 997-1007   Medline

     

  9. Mimicking dominant negative inhibition of prion replication through structure-based drug design.
    Perrier V, Wallace AC, Kaneko K, Safar J, Prusiner SB, Cohen FE.
    Proc Natl Acad Sci U S A 2000, 97: 6073-8   Medline

     

  10. Report on Prions, International Commission on the Taxonomy of Viruses.
    Prusiner SB, Baron H, Carlson G, Cohen FE, DeArmond SJ, Gabizon R, Gambetti P, Hope J, Kitamoto T, Laplanche J-L, Tateishi J, Telling G, Will R.
    7th Edition Springer-Verlag Wien New York 2000.

     

  11. Prion Protein Structures.
    Prusiner SB, Cohen FE.
    In Prion Biology and Diseases ed SB Prusiner Cold Spring Harbor Laboratory Press Cold Spring Harbor New York 2000 pp..

     

  12. Quantitative traits of prion strains are enciphered in the conformation of the prion protein.
    Safar J, Cohen FE, Prusiner SB.
    Arch Virol Suppl 2000 227-35   Medline

     

  13. Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss.
    Silverman GL, Qin K, Moore RC, Yang Y, Mastrangelo P, Tremblay P, Prusiner SB, Cohen FE, Westaway D.
    J Biol Chem 2000, 275: 26834-41   Medline

     

  14. Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations.
    Supattapone S, Nguyen HO, Muramoto T, Cohen FE, DeArmond SJ, Prusiner SB, Scott M.
    J Virol 2000, 74: 11928-34   Medline

     

  15. Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei.
    Troeberg L, Chen X, Flaherty TM, Morty RE, Cheng M, Hua H, Springer C, McKerrow JH, Kenyon GL, Lonsdale-Eccles JD, Coetzer TH, Cohen FE.
    Mol Med 2000, 6: 660-9   Medline

     

  16. Reconstruction of Low-Resolution Three-Dimensional Density Maps From One-Dimensional Small-Angle X-Ray.
    Walther D, Cohen FE, Doniach S.
    J Appl Cryst 2000, 33: 350-363

     

  17. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.
    Whittal RM, Ball HL, Cohen FE, Burlingame AL, Prusiner SB, Baldwin MA.
    Protein Sci 2000, 9: 332-43   Medline

     

  18. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
    Wille H, Prusiner SB, Cohen FE.
    J Struct Biol 2000, 130: 323-38   Medline

     

  19. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.
    Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, Prusiner SB.
    J Virol 2000, 74: 4351-60   Medline

     

     


    home-research-people-publications-media releases-software-links-contact

     

    webmaster@cmpharm.ucsf.edu
    Automatically generated (Powered by Python and F.Horn)
    Last modified 04-Jan-2005
    Copyright 2005 The University of California, San Francisco, CA
    Regents of the University of California